UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash Flows From Operating Activities:
Consolidated Net Income	$ 17,843	$ 20,455	$ 48,619	$ 55,219
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Provision for Credit Losses	1,665	604	4,161	4,364
Depreciation and Amortization			3,693	3,546
Net Accretion of Purchase Accounting Adjustments			(1,788)	(6,159)
Stock Based Compensation Cost			989	2,665
Net Amortization of Securities			1,738	3,241
Loss on Sales of Securities			14	62
Gain on Sale of Loans			(2,299)	(375)
Income on Other Equity Securities			(1,723)	(3,826)
Gain on Sale of Other Real Estate Owned, Net of Writedowns			(49)	(308)
Increase in Cash Value of Life Insurance			(1,884)	(1,675)
Deferred Income Tax Expense			996	2,121
Gain on Sale of Branch			0	(932)
Changes in Assets and Liabilities:
Increase in Accrued Interest Receivable			(2,631)	(2,394)
Increase in Other Assets			(4,339)	(3,313)
Increase (Decrease) in Accrued Interest Payable			(11,089)	9,096
Increase in Other Liabilities			9,664	9,816
Net Cash Provided by Operating Activities			44,072	71,148
Cash Flows From Investing Activities:
Purchases of Securities Available for Sale			(92,345)	(46,211)
Proceeds from Maturities / Sales of Securities Available for Sale			27,964	17,320
Proceeds from Paydowns of Securities Available for Sale			52,011	42,688
Net Cash Paid in Acquisition			(3,279)	0
Net Cash Paid in Sale of Branch			0	(14,506)
Purchases of Other Equity Securities			(4,539)	(13,961)
Redemption of Other Equity Securities			663	21,212
Purchase of Life Insurance			(3,000)	(2,273)
Net Increase in Loans			(224,512)	(307,487)
Net Purchases of Premises and Equipment			(1,837)	(5,718)
Loss on Disposal of Premises and Equipment			7	0
Proceeds from Sales of Other Real Estate			589	1,240
Net Increase in Securities Purchased Under Agreements to Resell			(25,879)	0
Net Increase in Federal Funds Sold			(18,846)	(181,010)
Net Cash Used in Investing Activities			(293,003)	(488,706)
Cash Flows From Financing Activities:
Net Increase in Deposits			392,156	386,713
Net Increase in Securities Sold Under Agreements to Repurchase			2,644	3,037
Net Decrease in Federal Funds Purchased			0	(14,057)
Net Advances (Repayments) on Federal Home Loan Bank Borrowings			156,004	(195,916)
Net Proceeds (Repayments) on Bank Term Funding Program			(300,000)	300,000
Repayment of Subordinated Debt			0	(8,900)
Gain on Extinguishment of Debt			0	(1,458)
Costs from Issuance of Common Stock			(31)	0
Payment of Dividends on Preferred Stock			(4,051)	(4,051)
Payment of Dividends on Common Stock			(10,702)	(9,089)
Net Cash Provided by Financing Activities			236,020	456,279
Net Increase (Decrease) in Cash and Cash Equivalents			(12,911)	38,721
Cash and Cash Equivalents at Beginning of Period			226,110	152,740	$ 152,740
Cash and Cash Equivalents at End of Period	213,199	191,461	213,199	191,461	$ 226,110
Supplemental Disclosures for Cash Flow Information:
Interest on Deposits			121,562	71,039
Interest on Borrowings			26,495	17,158
Income Tax Payments			11,101	9,489
Supplemental Schedule for Noncash Investing and Financing Activities:
Change in the Unrealized Gain (Loss) on Securities Available for Sale			25,902	(23,947)
Change in the Unrealized Gain (Loss) on Equity Securities	$ 0	$ (8)	14	(1,451)
Change in Deferred Tax Effect on the Unrealized (Gain) Loss on Securities Available for Sale			(5,475)	5,366
Transfer of Loans to Other Real Estate			$ 642	$ 1,118